We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 4,343 results
  1. Influenza Virus

    The rapid diagnosis of patients in clinical practice is important for anti-influenza therapy. However, since the sensitivity of conventional rapid...
    Teruhiko Matsubara, Toshinori Sato in Diamond Electrodes
    Chapter 2022
  2. Recent Developments in the Treatment of Influenza

    Influenza infections are associated with elevated levels of mortality and morbidity in young children, the elderly, and the immunocompromised....
    Lachlan Shiver, Caroline Ward, ... Charles Preuss in Viral Drug Delivery Systems
    Chapter 2023
  3. Medicinal Plants in the Treatment of Diseases Caused by Influenza B Virus and Parainfluenza Virus Type 3

    A tiny sort of parasite with a size range of 0.02–0.3 mm, viruses are made up of two primary components: genetic material (DNA or RNA) and a protein...
    Shephali Patra, Amit Naskar, ... Arindam Maity in Anti-Viral Metabolites from Medicinal Plants
    Reference work entry 2024
  4. Multiplexed electrochemical liposomes applied to the detection of nucleic acids for Influenza A, Influenza B and SARS-CoV-2

    Multiplexing is a relevant strategy for biosensors to improve accuracy and decision-making due to the increased amount of simultaneously obtained...

    Florian Gerstl, Michael Loessl, ... Antje J. Baeumner in Analytical and Bioanalytical Chemistry
    Article Open access 19 January 2024
  5. Influenza Vaccine: An Engineering Vision from Virological Importance to Production

    According to data from the World Health Organization (WHO) every year, millions of people are affected by flu. Flu is a disease caused by influenza...

    S. Furkan Demirden, Kadir Alptekin, ... Suphi S. Oncel in Biotechnology and Bioprocess Engineering
    Article 24 October 2022
  6. Medicinal Plants in the Treatment of Influenza Virus A Infections: Role of Secondary Metabolites, Clinical and Preclinical Studies, and Future Perspectives

    In the current period, respiratory diseases that evolved from influenza A infection have become a burning issue to the communities throughout the...
    Chandi Charan Kandar, Dilipkumar Pal in Anti-Viral Metabolites from Medicinal Plants
    Reference work entry 2024
  7. CRISPR/Cas13a combined with hybridization chain reaction for visual detection of influenza A (H1N1) virus

    This study provides proof of concept of a colorimetric biosensor for influenza H1N1 virus assay based on the CRISPR/Cas13a system and hybridization...

    Hongyu Zhou, Shengjun Bu, ... Feng Tang in Analytical and Bioanalytical Chemistry
    Article 20 October 2022
  8. Quantitative performance of digital ELISA for the highly sensitive quantification of viral proteins and influenza virus

    A single-molecule assay (SiMoA) using a digital enzyme-linked immunosorbent assay (ELISA) has been attracting attention as a promising method that...

    Takema Hasegawa, Sachie Shibayama, ... Megumi Kato in Analytical and Bioanalytical Chemistry
    Article 23 February 2023
  9. Probing the Ononin and Corylin molecules against anti-influenza H1N1 A virus: a detailed active site analysis

    Ononin and Corylin drug molecules exhibit antiviral effects against the H1N1 influenza A virus, with IC 50 values of 30% at 200 µM and > 115 µM,...

    Sathya Bangaru, Keerthivasan Thamotharan, ... Ramasamy Perumalsamy in Research on Chemical Intermediates
    Article 01 June 2023
  10. Production of Influenza Virus Glycoproteins Using Insect Cells

    The baculovirus/insect cell expression system is a very useful tool for reagent and antigen generation in vaccinology, virology, and immunology. It...
    Madhumathi Loganathan, Benjamin Francis, Florian Krammer in Recombinant Glycoproteins
    Protocol 2024
  11. A novel “prime and pull” strategy mediated by the combination of two dendritic cell-targeting designs induced protective lung tissue-resident memory T cells against H1N1 influenza virus challenge

    Vaccination is still the most promising strategy for combating influenza virus pandemics. However, the highly variable characteristics of influenza...

    Zhannan Wang, Yingkai He, ... Chunfeng Wang in Journal of Nanobiotechnology
    Article Open access 13 December 2023
  12. Reverse Vaccinology for Influenza A Virus: From Genome Sequencing to Vaccine Design

    Reverse vaccinology (RV) consists in the identification of potentially protective antigens expressed by any organism starting from genomic...
    Valentina Di Salvatore, Giulia Russo, Francesco Pappalardo in Computational Vaccine Design
    Protocol 2023
  13. A practical and rapid screening method for influenza virus neuraminidase inhibitors based on fluorescence detection

    A new analytical method for rapid screening of influenza virus neuraminidase inhibitors was established. The method is based on the principle that,...

    Junjie **e, Peng Tan, ... Lu Hao in Analytical Sciences
    Article 08 January 2023
  14. A New Quantum Dot-Based Lateral Flow Immunoassay for the Rapid Detection of Influenza Viruses

    Rapid and accurate diagnosis of influenza is crucial to contain influenza virus outbreaks. In clinical settings, lateral flow immunoassays (LFIAs)...

    Soo-Kyung Kim, Heungsup Sung, ... Mi-Na Kim in BioChip Journal
    Article 21 March 2022
  15. Increasing the Water Solubility of N-Acyl-Substituted Amino Acid Esters as Inhibitors of the Replication of Modern Influenza A Virus Strains In Vitro by Zinc(II) Complexation

    Abstract

    This article proposes carbocyclic derivatives of N-acylated esters of L-amino acids with aromatic carboxylic acids as antiviral...

    T. M. Garaev, I. I. Yudin, ... E. A. Malinina in Russian Journal of Inorganic Chemistry
    Article 28 March 2024
  16. Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants

    Viruses are a major cause of mortality and socio-economic downfall despite the plethora of biopharmaceuticals designed for their eradication....

    Esmaeel Sharifi, Satar Yousefiasl, ... Franklin R. Tay in Journal of Nanobiotechnology
    Article Open access 21 June 2023
  17. UiO-66 nanoparticles combat influenza A virus in mice by activating the RIG-I-like receptor signaling pathway

    The Influenza A virus (IAV) is a zoonotic pathogen that infects humans and various animal species. Infection with IAV can cause fever, anorexia, and...

    Rui**g Su, **nsen Li, ... Yanxin Hu in Journal of Nanobiotechnology
    Article Open access 09 March 2024
  18. Production of Neuraminidase Virus Like Particles by Stably Transformed Insect Cells: A Simple Process for NA-Based Influenza Vaccine Development

    Neuraminidase (NA) is a second major surface protein of the influenza virus and has recently been suggested as a supplemental antigen to the major...

    Najmeh Khanefard, Saithip Sapavee, ... Kanokwan Poomputsa in Molecular Biotechnology
    Article 15 June 2022
  19. One-Step Homogeneous Immunoassay for the Detection of Influenza Virus Using Switching Peptide and Graphene Quencher

    One-step homogeneous immunoassay was developed for detecting influenza viruses A and B (Inf-A and Inf-B) using the switching peptide H2. As the...

    Hong-Rae Kim, Ji-Hong Bong, ... Jae-Chul Pyun in BioChip Journal
    Article 27 July 2022
  20. Antigenic characterization of influenza and SARS-CoV-2 viruses

    Antigenic characterization of emerging and re-emerging viruses is necessary for the prevention of and response to outbreaks, evaluation of infection...

    Yang Wang, Cynthia Y. Tang, **u-Feng Wan in Analytical and Bioanalytical Chemistry
    Article 14 December 2021
Did you find what you were looking for? Share feedback.